The company is significantly boosting its R&D investments to maintain its product pipeline and drive future growth.
Filing excerpt
During the first quarter of 2026, R&D expenses increased $72 million, or 16 percent, compared to the prior year period and were 40 basis points higher as a percentage of net sales.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10qcapexIncreaseGet every 10-Q signal for Boston Scientific and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/cc126c1f-d626-4a81-8ac0-52b3a69b779e returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.
{
"signal_id": "cc126c1f-d626-4a81-8ac0-52b3a69b779e",
"signal_type": "sec-10q",
"signal_subtype": "capexIncrease",
"detected_at": "2026-05-05T08:48:21.792+00:00",
"company": {
"name": "Boston Scientific",
"domain": "bostonscientific.com"
},
"data": {
"detail": "The company is significantly boosting its R&D investments to maintain its product pipeline and drive future growth. This budget increase signals an opportunity for vendors providing R&D-related software, lab equipment, and clinical trial management solutions.",
"metrics": {
"pct": 0.16,
"timeframe": "current_quarter",
"pct_context": "Increase in R&D expenses",
"dollar_context": "Increase in R&D expenses in Q1 2026 vs Q1 2025",
"dollar_millions": 72
},
"summary": "Increased R&D spending by $72M (16%) in Q1 to fuel product pipeline.",
"excerpts": "During the first quarter of 2026, R&D expenses increased $72 million, or 16 percent, compared to the prior year period and were 40 basis points higher as a percentage of net sales.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000033/bsx-20260331.htm",
"filing_date": "2026-05-01",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Budget available",
"signal_category": "financial"
}
}
curl https://signals.autobound.ai/v1/signals/cc126c1f-d626-4a81-8ac0-52b3a69b779e \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bostonscientific.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.